Andrew Tindall

Andrew Tindall
Andrew is a member of our life sciences patent team working in the biotechnology sector. His technical experience includes: molecular and cell biology, antibody technology, microbiology, plant engineering and glycosaminoglycan sugars. Andrew has experience in drafting and prosecuting patent applications for local and international clients. He also works on freedom to operate and patent landscape analysis.

Recent Posts

Plant related inventions: clarity at last?

Andrew Tindall

Andrew Tindall
06 Feb 2019

As we reported previously, EPO Technical Board of Appeal 3304 recently ruled that a controversial prohibition at the EPO against the grant of patents for.